Global siRNA Drugs Market Growth (Status and Outlook) 2024-2030

Small interfering RNA (siRNA), sometimes known as short interfering RNA or silencing RNA, is a class of double-stranded RNA at first non-coding RNA molecules, typically 20–24 (normally 21) base pairs in length, similar to miRNA, and operating within the RNA interference (RNAi) pathway. siRNA plays a crucial role in gene silencing and regulation of gene expression. siRNA-based therapeutics have gained significant attention in recent years due to their potential to target specific genes involved in diseases such as cancer, genetic disorders, viral infections, and neurodegenerative diseases. The scope of siRNA drug products encompasses various aspects, including their design, development, testing, and regulatory approval.

The global siRNA Drugs market size is projected to grow from US$ 2391 million in 2024 to US$ 13310 million in 2030; it is expected to grow at a CAGR of 33.1% from 2024 to 2030.

LPI (LP Information)' newest research report, the “siRNA Drugs Industry Forecast” looks at past sales and reviews total world siRNA Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected siRNA Drugs sales for 2023 through 2029. With siRNA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world siRNA Drugs industry.

This Insight Report provides a comprehensive analysis of the global siRNA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on siRNA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global siRNA Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for siRNA Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global siRNA Drugs.

Core manufacturers of siRNA Drugs include Alnylam, Novartis, Novo Nordisk, Genzyme and Arrowhead. USA is the largest consumption region, accounting for approximately 57% of the global market, followed by Europe. In terms of product type, subcutaneous injection are the largest market segment, with a share of more than 77%. In terms of product application, the largest application market is nervous system therapy, with a share of approximately 52%.

This report presents a comprehensive overview, market shares, and growth opportunities of siRNA Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Intravenous Injection
    Subcutaneous Injection

Segmentation by Application:
    Nervous System Therapy
    Endocrine and Metabolic Therapy
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    Intravenous Injection
    Subcutaneous Injection

Segmentation by Application:
    Nervous System Therapy
    Endocrine and Metabolic Therapy
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Alnylam
    Novartis
    Novo Nordisk
    Genzyme
    Arrowhead
    Silence
    Sylentis
    Avidity Biosciences
    Sirnaomics

List of Tables
 Table 1. siRNA Drugs Market Size CAGR by Region (2025-2030) ($ millions)
 Table 2. Major Players of Intravenous Injection
 Table 3. Major Players of Subcutaneous Injection
 Table 4. Global Market Size by Type (2025-2030) ($ millions)
 Table 5. Global siRNA Drugs Market Size Market Share by Type (2025-2030)
 Table 6. Global siRNA Drugs Market Size by Application (2025-2030) ($ millions)
 Table 7. Global siRNA Drugs Market Size Market Share by Application (2025-2030)
 Table 8. Date of Global Key Players Enter into siRNA Drugs Market
 Table 9. Global Key Players siRNA Drugs Product Offered
 Table 10. Key Players siRNA Drugs Funding/Investment (Million USD)
 Table 11. Funding/Investment by Regions
 Table 12. Funding/Investment by End-Industry
 Table 13. Key Players siRNA Drugs Valuation & Market Capitalization (Million USD)
 Table 14. Key Players Mergers & Acquisitions, Expansion Plans
 Table 15. siRNA Drugs New Product/Technology Launches
 Table 16. siRNA Drugs Industry Partnerships, Agreements, and Collaborations
 Table 17. siRNA Drugs Industry Mergers and Acquisitions
 Table 18. Global siRNA Drugs Market Size by Regions 2025-2030 ($ millions)
 Table 19. Global siRNA Drugs Market Size Market Share by Regions 2025-2030
 Table 20. United States siRNA Drugs Market Size by Type (2025-2030) ($ millions)
 Table 21. United States siRNA Drugs Market Size Market Share by Type (2025-2030)
 Table 22. United States siRNA Drugs Market Size by Application (2025-2030) ($ millions)
 Table 23. United States siRNA Drugs Market Size Market Share by Application (2025-2030)
 Table 24. Europe siRNA Drugs Market Size by Type (2025-2030) ($ millions)
 Table 25. Europe siRNA Drugs Market Size Market Share by Type (2025-2030)
 Table 26. Europe siRNA Drugs Market Size by Application (2025-2030) ($ millions)
 Table 27. Europe siRNA Drugs Market Size Market Share by Application (2025-2030)
 Table 28. China siRNA Drugs Market Size by Type (2025-2030) ($ millions)
 Table 29. China siRNA Drugs Market Size Market Share by Type (2025-2030)
 Table 30. China siRNA Drugs Market Size by Application (2025-2030) ($ millions)
 Table 31. China siRNA Drugs Market Size Market Share by Application (2025-2030)
 Table 32. Rest of World siRNA Drugs Market Size by Type (2025-2030) ($ millions)
 Table 33. Rest of World siRNA Drugs Market Size Market Share by Type (2025-2030)
 Table 34. Rest of World siRNA Drugs Market Size by Application (2025-2030) ($ millions)
 Table 35. Rest of World siRNA Drugs Market Size Market Share by Application (2025-2030)
 Table 36. Key Market Drivers & Growth Opportunities of siRNA Drugs
 Table 37. Key Market Challenges & Risks of siRNA Drugs
 Table 38. Key Industry Trends of siRNA Drugs
 Table 39. Company A Company Details
 Table 40. Companies Invested by Company A
 Table 41. Company A Key Development and Market Layout
 Table 42. Company B Company Details
 Table 43. Companies Invested by Company B
 Table 44. Company B Key Development and Market Layout
 Table 45. Company C Company Details
 Table 46. Companies Invested by Company C
 Table 47. Company C Key Development and Market Layout
 Table 48. Alnylam Basic Information, Head Office, Major Market Areas and Its Competitors
 Table 49. Alnylam siRNA Drugs Market Size (2023 VS 2028)
 Table 50. Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
 Table 51. Novartis siRNA Drugs Market Size (2023 VS 2028)
 Table 52. Novo Nordisk Basic Information, Head Office, Major Market Areas and Its Competitors
 Table 53. Novo Nordisk siRNA Drugs Market Size (2023 VS 2028)
 Table 54. Genzyme Basic Information, Head Office, Major Market Areas and Its Competitors
 Table 55. Genzyme siRNA Drugs Market Size (2023 VS 2028)
 Table 56. Arrowhead Basic Information, Head Office, Major Market Areas and Its Competitors
 Table 57. Arrowhead siRNA Drugs Market Size (2023 VS 2028)
 Table 58. Silence Basic Information, Head Office, Major Market Areas and Its Competitors
 Table 59. Silence siRNA Drugs Market Size (2023 VS 2028)
 Table 60. Sylentis Basic Information, Head Office, Major Market Areas and Its Competitors
 Table 61. Sylentis siRNA Drugs Market Size (2023 VS 2028)
 Table 62. Avidity Biosciences Basic Information, Head Office, Major Market Areas and Its Competitors
 Table 63. Avidity Biosciences siRNA Drugs Market Size (2023 VS 2028)
 Table 64. Sirnaomics Basic Information, Head Office, Major Market Areas and Its Competitors
 Table 65. Sirnaomics siRNA Drugs Market Size (2023 VS 2028)


List of Figures
 Figure 1. Picture of siRNA Drugs
 Figure 2. siRNA Drugs Report Years Considered
 Figure 3. Research Objectives
 Figure 4. Research Methodology
 Figure 5. Research Process and Data Source
 Figure 6. Global siRNA Drugs Market Size Growth Rate 2025-2030 ($ millions)
 Figure 7. siRNA Drugs Market Size by Region (2024 & 2030) ($ millions)
 Figure 8. Global siRNA Drugs Market Size Market Share by Type (2025-2030)
 Figure 9. Global Intravenous Injection Market Size Growth Rate
 Figure 10. Global Subcutaneous Injection Market Size Growth Rate
 Figure 11. siRNA Drugs in Nervous System Therapy
 Figure 12. Global siRNA Drugs Market: Nervous System Therapy (2025-2030) ($ millions)
 Figure 13. siRNA Drugs in Endocrine and Metabolic Therapy
 Figure 14. Global siRNA Drugs Market: Endocrine and Metabolic Therapy (2025-2030) ($ millions)
 Figure 15. siRNA Drugs in Others
 Figure 16. Global siRNA Drugs Market: Others (2025-2030) ($ millions)
 Figure 17. Global siRNA Drugs Market Size Market Share by Application (2025-2030)
 Figure 18. Global siRNA Drugs Market Size in Nervous System Therapy Growth Rate
 Figure 19. Global siRNA Drugs Market Size in Endocrine and Metabolic Therapy Growth Rate
 Figure 20. Funding/Investment
 Figure 21. Global siRNA Drugs Market Size Market Share by Regions 2025-2030
 Figure 22. United States siRNA Drugs Market Size 2025-2030 ($ millions)
 Figure 23. China siRNA Drugs Market Size 2025-2030 ($ millions)
 Figure 24. Europe siRNA Drugs Market Size 2025-2030 ($ millions)
 Figure 25. Rest of World siRNA Drugs Market Size 2025-2030 ($ millions)
 Figure 26. United States siRNA Drugs Consumption Market Share by Type in 2028
 Figure 27. United States siRNA Drugs Market Size Market Share by Application in 2028
 Figure 28. Europe siRNA Drugs Consumption Market Share by Type in 2028
 Figure 29. Europe siRNA Drugs Market Size Market Share by Application in 2028
 Figure 30. China siRNA Drugs Consumption Market Share by Type in 2028
 Figure 31. China siRNA Drugs Market Size Market Share by Application in 2028
 Figure 32. Rest of World siRNA Drugs Consumption Market Share by Type in 2028
 Figure 33. Rest of World siRNA Drugs Market Size Market Share by Application in 2028

Alnylam
Novartis
Novo Nordisk
Genzyme
Arrowhead
Silence
Sylentis
Avidity Biosciences
Sirnaomics

LP Information presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

• Primary Source
  Players/Suppliers
  Industry Experts
  Distributors/Traders
  Opinion Leaders
  Front-line Staff
  Marketing Executives

  Secondary Source
  Journals and Periodicals
  Government Bodies
  Annual Reports
  Presentations
  Paid Databases
  LPI Internal Repository

• Data Synthesis
  Information Gathering
  Collation of Data
  Estimation of Key Figures
  Analysis of Derived Insights

  Data Validation
  Triangulation with Data Models
  Reference Against Proprietary
  Databases
  Corroboration with Industry Experts

• Qualitative Analysis
  Market drivers
  Market challenges
  Market trends
  Five forces analysis

  Qualitative Analysis
  Market size and forecast
  Market segmentation
  Geographical insights
  Competitive landscape